Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 121 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/16
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/27/24
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 12/01/20
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 08/01/20
End: 06/30/21
Due: 06/30/22
Phase: N/A
Priority: Normal
Start: 09/01/19
End: 09/01/22
Due: 09/01/23
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 09/30/19
Due: 09/30/20
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 08/31/19
Due: 08/31/20
Phase: N/A
Priority: Normal
Start: 12/31/19
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 01/08/22
End: 11/30/29
Due: 11/30/30
Phase: N/A
Priority: Normal
Start: 06/04/20
End: 07/01/27
Due: 07/01/28
Phase: N/A
Priority: Normal
Start: 04/01/19
End: 10/30/23
Due: 10/30/24
Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)
Phase: N/A
Priority: Normal
Start: 03/30/19
End: 09/30/19
Due: 09/30/20
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 11/01/23
End: 10/31/25
Due: 10/31/26
Phase: N/A
Priority: Normal
Start: 12/01/23
End: 10/10/24
Due: 10/10/25
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 12/01/20
End: 12/01/22
Due: 12/01/23
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 01/20/20
End: 02/28/21
Due: 02/28/22
Phase: N/A
Priority: Normal
Start: 01/31/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/01/15
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 01/17/19
End: 03/31/23
Due: 03/31/24
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 01/01/23
Due: 01/01/24